Luca Campedel

597 total citations
26 papers, 93 citations indexed

About

Luca Campedel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Luca Campedel has authored 26 papers receiving a total of 93 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 6 papers in Surgery. Recurrent topics in Luca Campedel's work include Renal cell carcinoma treatment (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Luca Campedel is often cited by papers focused on Renal cell carcinoma treatment (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Luca Campedel collaborates with scholars based in France, United States and Switzerland. Luca Campedel's co-authors include Paul Blanc‐Durand, Emmanuel Itti, Simon Jégou, Alain Luciani, Sebastien Mulé, F. Pigneur, Noël Zahr, Paul Gougis, Christian Funck‐Brentano and Nizar M. Tannir and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and The Oncologist.

In The Last Decade

Luca Campedel

19 papers receiving 91 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luca Campedel France	6	42	32	20	17	17	26	93
Punam Rana Canada	5	25 0.6×	55 1.7×	23 1.1×	8 0.5×	14 0.8×	9	105
Esmée C. de Baat Netherlands	6	57 1.4×	51 1.6×	37 1.9×	26 1.5×	7 0.4×	7	208
Luis Eduardo Rosa Zucca Brazil	5	42 1.0×	26 0.8×	31 1.6×	9 0.5×	12 0.7×	9	82
Danny Houtsma Netherlands	6	38 0.9×	42 1.3×	22 1.1×	5 0.3×	22 1.3×	19	98
Elles M. Screever Netherlands	10	18 0.4×	52 1.6×	40 2.0×	14 0.8×	9 0.5×	16	201
Ryota Shirai Japan	7	18 0.4×	11 0.3×	31 1.6×	16 0.9×	11 0.6×	10	97
Helen Higgins United Kingdom	6	15 0.4×	64 2.0×	17 0.8×	24 1.4×	37 2.2×	19	112
Nikolay Kislov Russia	7	54 1.3×	48 1.5×	14 0.7×	8 0.5×	17 1.0×	13	105
Bruno Chiurazzi Italy	5	24 0.6×	50 1.6×	31 1.6×	8 0.5×	6 0.4×	12	118
John McGrane United Kingdom	7	50 1.2×	75 2.3×	25 1.3×	20 1.2×	19 1.1×	29	139

Countries citing papers authored by Luca Campedel

Since Specialization

Citations

This map shows the geographic impact of Luca Campedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Campedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Campedel more than expected).

Fields of papers citing papers by Luca Campedel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Campedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Campedel. The network helps show where Luca Campedel may publish in the future.

Co-authorship network of co-authors of Luca Campedel

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Campedel. A scholar is included among the top collaborators of Luca Campedel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Campedel. Luca Campedel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fléchon, Aude, G. Pignot, J. Rigaud, et al.. (2025). Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients. BJUI Compass. 6(7). e70056–e70056.

Corbaux, Pauline, Nicolas Stocker, Pauline Afchain, et al.. (2024). Patients’ knowledge about renal secondary effects of anti-tumoral drugs and renal protection measures. Supportive Care in Cancer. 32(11). 763–763.

Oudard, Stéphane, Marc‐Olivier Timsit, Denis Maillet, et al.. (2024). Cancer de prostate métastatique résistant à la castration et inhibiteurs de PARP : de la génomique tumorale aux nouvelles associations thérapeutiques. Bulletin du Cancer. 112(1). 61–81.

Gougis, Paul, et al.. (2024). Radiotherapy for oligoprogressive disease in non-small cell lung cancer treated with pembrolizumab in first-line setting: a retrospective study. Translational Lung Cancer Research. 13(12). 3603–3615.

Bihan, Kévin, Corinne Isnard Bagnis, Noël Zahr, et al.. (2023). Management of cancer treatments in hemodialysis patients. Bulletin du Cancer. 111(7-8). 701–719. 2 indexed citations

Alhalabi, Omar, Sylvie Négrier, Yann Vano, et al.. (2023). Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas. The Oncologist. 28(5). 433–439. 13 indexed citations

Thibault, Constance, Mostefa Bennamoun, Aude Fléchon, et al.. (2023). 2364MO Durvalumab (D) +/- tremelimumab (T) in combination with dose-dense MVAC (ddMVAC) as neoadjuvant treatment in patients with muscle-invasive bladder carcinoma (MIBC): Results of NEMIO, a randomized phase I-II trial. Annals of Oncology. 34. S1202–S1202. 5 indexed citations

Alexandre, Jérôme, Stéphane Oudard, Luca Campedel, et al.. (2023). Intra-individual dose escalation of abiraterone (ABI) according to its plasma exposure in patients (pts) with progressive metastatic castration-resistant prostate cancer (mRCPC): Results of the OPTIMABI trial.. Journal of Clinical Oncology. 41(6_suppl). 159–159. 1 indexed citations

Colomba, Émeline, Luca Campedel, Clément Dumont, et al.. (2022). Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study. Cancers. 14(7). 1678–1678. 7 indexed citations

10.

Gougis, Paul, Arthur Géraud, Marc Hilmi, et al.. (2022). Cytochrome P-450-mediated herb and food–drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study. ESMO Open. 7(6). 100650–100650. 1 indexed citations

11.

Delaye, Matthieu, et al.. (2022). Onco-nephrology: Physicians’ Expectations About a New Subspecialty. Journal of Cancer Education. 38(3). 878–884. 2 indexed citations

12.

Alhalabi, Omar, Sylvie Négrier, Yann Vano, et al.. (2022). Immuno-oncology (IO) combinations +/- VEGF targeted therapy (VEGF TT) in patients (pts) with advanced mit family translocation renal cell carcinomas (tRCC): Results from an international multicenter study.. Journal of Clinical Oncology. 40(6_suppl). 343–343. 1 indexed citations

13.

Zysman, M., Boris Duchemann, André Gillibert, et al.. (2022). Incidence, management, and outcome of lung cancer in patients with long‐term oxygen therapy. Thoracic Cancer. 14(1). 36–43. 1 indexed citations

14.

Fenioux, Charlotte, Yves Allenbach, Aurore Vozy, et al.. (2021). Comparaison des caractéristiques et des pronostics des patients avec et sans cancer actif hospitalisés pour une infection à SARS-CoV-2. Bulletin du Cancer. 108(6). 581–588. 3 indexed citations

15.

Gougis, Paul, Fleur Cohen‐Aubart, Luca Campedel, et al.. (2021). Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis. 197. 113968–113968. 18 indexed citations

16.

Delaye, Matthieu, Noël Zahr, Corinne Isnard Bagnis, Paul Gougis, & Luca Campedel. (2021). [Kidney function and cancer treatment: which problems for the oncologist?]. PubMed. 71(2). 206–211. 1 indexed citations

17.

Blanc‐Durand, Paul, Luca Campedel, Sebastien Mulé, et al.. (2020). Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer. European Radiology. 30(6). 3528–3537. 23 indexed citations

18.

Campedel, Luca, Paul Blanc‐Durand, Jacqueline Lehmann‐Che, et al.. (2020). Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC. Cancers. 12(9). 2657–2657. 6 indexed citations

19.

Campedel, Luca, Thomas Seisen, Olivier Cussenot, et al.. (2018). Intérêt pronostique de l’expression de PD-1/PD-L1 dans les tumeurs de la voie excrétrice urinaire supérieure. Progrès en Urologie. 28(16). 900–905.

20.

Campedel, Luca, Myriam Kossaï, Paul Blanc‐Durand, et al.. (2017). Le cancer de la prostate neuro-endocrine : histoire naturelle, caractéristiques moléculaires, prise en charge et perspectives. Bulletin du Cancer. 104(9). 789–799. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact